MIRA Pharmaceuticals Inc.

NASDAQ: MIRA · Real-Time Price · USD
1.51
0.04 (2.72%)
At close: Aug 15, 2025, 3:59 PM
1.48
-1.97%
After-hours: Aug 15, 2025, 07:51 PM EDT

MIRA Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
2.83M 4.6M 350.98K 2.81M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a 69.15K n/a n/a
Other Long-Term Assets
35.44K 69.15K n/a 445.61K
Receivables
n/a 11.86K n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
n/a n/a 143.43K 100K
Total Current Assets
2.89M 4.86M 494.4K 2.91M
Property-Plant & Equipment
n/a 5.06K 363.67K n/a
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
35.44K 74.21K 363.67K 445.61K
Total Assets
2.92M 4.93M 858.07K 3.36M
Account Payables
723.35K 538.56K 905.55K 776.01K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a 5.06K 133.06K 293.06K
Other Current Liabilities
n/a n/a n/a n/a
Total Current Liabilities
723.35K 558.1K 1.37M 1.09M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
n/a n/a 84.27K n/a
Total Liabilities
723.35K 558.1K 1.45M 1.09M
Total Debt
n/a 5.06K 491.23K 293.06K
Common Stock
1.66K 1.48K 6.66K 6.34K
Retained Earnings
-29.14M -21.29M -9.3M -2.24M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
2.2M 4.37M -596.23K 2.26M
Total Investments
n/a 69.15K n/a n/a